Documente Academic
Documente Profesional
Documente Cultură
Diagrams
Omar Lababede, Moulay Meziane and Thomas Rice Chest 2011;139;183-189 DOI 10.1378/chest.10-1099 The online version of this article, along with updated information and services can be found online on the World Wide Web at: http://chestjournal.chestpubs.org/content/139/1/183.full.html
Chest is the official journal of the American College of Chest Physicians. It has been published monthly since 1935. Copyright2011by the American College of Chest Physicians, 3300 Dundee Road, Northbrook, IL 60062. All rights reserved. No part of this article or PDF may be reproduced or distributed without the prior written permission of the copyright holder. (http://chestjournal.chestpubs.org/site/misc/reprints.xhtml) ISSN:0012-3692
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
CHEST
Quick Reference Chart and Diagrams
Special Features
Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer
Omar Lababede, MD; Moulay Meziane, MD; and Thomas Rice, MD, FCCP
Lung cancer remains the most common cause of cancer-related death in the United States. TNM staging, which is an important guide to the prognosis and treatment of lung cancer, has been revised recently. In this article, we propose a quick reference chart and diagrams that consolidate TNM staging information in a simple format. The current classication of lymph node stations and zones is illustrated as well. CHEST 2011; 139(1):183189
Abbreviations: M 5 metastases; N 5 regional lymph node involvement; T 5 primary tumor
is the leading cause of cancer Lungincancermen and women in the United mortality both States.
1
Staging plays a critical role in guiding treatment selection and determining prognosis of cancer. Additionally, the evaluation of the response to treatment and the clinical research of cancer are facilitated by a universal system. TNM staging provides a consistent, reproducible description of cancers based on the extent of anatomic involvement. This is achieved by dening the characteristics of the primary tumor (T), regional lymph node involvement (N), and metastases (M). The seventh edition of TNM staging for lung tumors has been released recently. The revisions in the new edition were recommended by the International Association for the Study of Lung Cancer staging project and were accepted by both the International Union Against Cancer and the American Joint Committee on Cancer.2-6 TNM staging of lung cancer is complex, and many variables must be considered (Tables 1, 2). It can be
Manuscript received April 27, 2010; revision accepted June 14, 2010. Afliations: From the Imaging Institute (Drs Lababede and Meziane) and the Department of Thoracic and Cardiovascular Surgery (Dr Rice), Cleveland Clinic, Cleveland, OH. Correspondence to: Omar Lababede, MD, Imaging Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195; e-mail: lababeo@ccf.org 2011 American College of Chest Physicians. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/ site/misc/reprints.xhtml). DOI: 10.1378/chest.10-1099
difcult to use and remember. We have designed a chart and two diagrams to present the new staging system in a simple, but nevertheless comprehensive, format. The comparative characteristics of the primary tumor are listed in the vertical columns of the chart (Fig 1). These features include size and extent (endobronchial location, local invasion, and satellite nodule[s]). The horizontal columns describe regional lymph node involvement. The different stage groupings are color coded and can be found at the intersections of appropriately matched horizontal and vertical columns. Stages with unique characteristics such as stages 0 and IV are dened in separate boxes. The basic design of the chart is based on our previously published reference chart of the fth edition of lung cancer staging.7 The diagrams (Fig 2) illustrate the same information in a more concise visual format. The recently adopted revisions of TNM staging are reected in our chart and diagrams. These changes include the following: TNM system application to small cell lung carcinoma and carcinoid tumor of the lung (the previous system was applicable to non-small cell lung carcinoma only) Redenition of the primary tumor classication based on size: T1 is subdivided into T1a and T1b T2 is subdivided into T2a and T2b Cancer larger than 7 cm is reclassied as T3.
CHEST / 139 / 1 / JANUARY, 2011
www.chestpubs.org
183
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Table 1Seventh Edition of TNM Staging of Lung Tumors: Denition of T, N, and M2-6
Descriptor Primary tumor (T) Tx T0 Tis T1 Denition Tumor that cannot be assessed or is not detected radiologically or bronchoscopically but is proven histopathologically (malignant cells in bronchopulmonary secretions) No evidence of primary tumor Carcinoma in situ Tumor with the following characteristics: Size 3 cm Airway location: in lobar bronchus or more distal airways Local invasion: none, surrounded by lung or visceral pleura Subdivisions: T1a (size 2 cm) and T1b (2 cm , size 3 cm) Tumor with size . 3 cm but 7 cm or tumor with any of the following characteristics: Airway location: involvement of the main bronchus (distance to the carina is 2 cm) or presence of atelectasis or obstructive pneumonitis that extends to hilar region but does not involve the entire lung Local invasion: involvement of visceral pleura Subdivisions: T2a (3 cm , size 5 cm) and T2b (5 cm , size 7 cm) Tumor . 7 cm in size or tumor with any of the following: Airway location: tumor in the main bronchus (within 2 cm of the carina), or tumor with atelectasis or obstructive pneumonitis of the entire lung Local invasion: direct invasion of chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, or parietal pericardium Satellite tumor nodule(s) in the same lobe as the primary tumor Tumor of any size invading any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; or tumor with satellite tumor nodule(s) in a different lobe, ipsilateral to that of the primary tumor Regional lymph nodes cannot be assessed Absence of regional lymph node involvement Presence of metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes (including direct extension to intrapulmonary nodes) Presence of metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes Presence of metastasis to any of the following lymph node groups: contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular nodes
T2
T3
T4
Distant metastasis (M) M0 Absence of distant metastasis M1 Presence of distant metastasis Subdivisions: M1a (satellite tumor nodule(s) in a contralateral lobe to that of the primary tumor or tumors with malignant pleural or pericardial effusion) M1b (distant metastasis) The uncommon supercial spreading tumor of any size with its invasive component limited to the bronchial wall is classied as T1a even in the case of extension to main bronchus.
Satellite nodule(s) in the same lobe as the primary tumor will now classify the tumor as T3 (previously T4), whereas their presence in a different lobe of the same lung is reclassied as T4 (previously M1).
Table 2Seventh Edition of TNM Staging of Lung Tumors: Stage Grouping2-6
Occult carcinoma Stage 0 Stage IA Stage IB Stage IIA Stage IIB Stage IIIA Stage IIIB Stage IV (TxN0M0) (TisN0M0) (T1a/bN0M0) (T2aN0M0) (T1a/bN1M0, T2aN1M0,T2bN0M0) (T2bN1M0, T3N0M0) (T(1-3)N2M0, T3N1M0, T4N(0-1)M0) (T4N2M0, T(1-4)N3M0) (Any T, any N, M1)
Redefinition of metastases (M): subdivision of M into M1a and M1b. M1a includes both satellite nodule(s) in the contralateral lung and malignant pleural and pericardial effusions. Malignant pleural and pericardial effusions were classied previously as T4 N0 Mx. Changes to stage groupings, including T4N0M0 and T4N1M0 tumors are reassigned from stage IIIB to stage IIIA. The newly dened T2b tumors with no lymph node or distant metastases (T2bN0M0) are grouped under IIA instead of IB. The newly dened T2a tumors with N1 lymph node but without distant metastases (T2aN1M0) are grouped under IIA rather than IIB.
Special Features
184
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Figure 1. Reference chart for 2009 TNM staging system of lung cancer. M 5 metastases; N 5 regional lymph node involvement; T 5 tumor.
Although regional lymph node (N) classications have not changed, a unied map of lymph node stations was adopted by the International Association for the Study of Lung Cancer.2,3,8 The new map recwww.chestpubs.org
onciles discrepancies among previous nodal mapping proposals and introduces the concept of lymph node zones (Table 3). Figures 3A and 3B demonstrate the new lymph nodes stations.
CHEST / 139 / 1 / JANUARY, 2011
185
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Figure 2. Reference diagrams for 2009 TNM staging system of lung cancer. The T classication can be dened by evaluating the size rst (upper left), then upgrading the classication (if necessary) based on the presence of the other criteria of primary tumor invasion/extent (A, B, and C). The criteria of extent should not be used to assign a lower classication. The lower diagram can be used to dene the N and M classication and to determine the corresponding stage. Note that N1, N2, N3, and the separate tumor nodule of M1a were depicted in the lower illustration based on a right-sided tumor (T). For left lung tumors, a mirror image of these descriptors should be used. Additionally, the endobronchial extension and local invasion (A and B of the criteria of extent) were shown in the upper illustration based on a left-sided tumor to simplify the drawing. See Figure 1 legend for expansion of abbreviations.
186
Special Features
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Upper mediastinal
2R
2L
3a 3p 4R
4L Aortopulmonary 5
6 Subcarinal 7
Left lower paratracheal Subaortic Lower border of the aortic arch (aortopulmonary window) Paraaortic (ascending Line tangential to the upper aorta or phrenic) limits of the aortic arch Subcarinal The carina
Lower mediastinal
8 (R and L)
Paraesophageal
9 (R and L)
Pulmonary ligaments
Upper border of lower lobe bronchus on the left and lower border of the bronchus intermedius on the right The inferior pulmonary vein
Diaphragm
Hilar/interlobar
10 (R and L)
Hilar
Peripheral
Lower rim of the azygos on the Interlobar regions right and upper rim of the left main pulmonary artery on the left Between the origin of the lobar bronchic Adjacent to the lobar bronchi Adjacent to the segmental bronchi Adjacent to the subsegmental bronchi
IASLC 5 International Association for the Study of Lung Cancer; L 5 left; R 5 right. aThe posterior sternum forms the anterior border of the prevascular nodes, whereas the posterior border is limited by the anterior border of the superior vena cava on the right side and the left carotid artery on the left side. bIncludes nodes adjacent to the main stem bronchi and hilar vessels, including the proximal aspects of the pulmonary arteries and veins. cCan be subdivided on the right into 11s (between the right upper lobe and bronchus intermedius) and 11i (between the middle and lower lobe bronchi).
www.chestpubs.org
187
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Figure 3. The International Association for the Study of Lung Cancer lymph node map depicted on views of the chest. A, right lateral view. B, left lateral view. The lymph node stations are color coded and grouped into zones. The colored arrows dene the anatomic limits of certain color-matching stations. AA 5 aortic arch; AAo 5 ascending aorta; Ao 5 aorta; AzV 5 azygos vein; BI 5 bronchus intermedius; C 5 carina; E 5 esophagus; IPV 5 inferior pulmonary vein; IV 5 innominate vein; L 5 left; LLLB 5 left lower lobe bronchus; LPA 5 left main pulmonary artery; PA 5 main pulmonary artery; PUL. LIG. 5 pulmonary ligament; R 5 right; RLLB 5 right lower lobe bronchus; SVC 5 superior vena cava; T 5 trachea.2,3,8
188
Special Features
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Figure 3. Continued.
Acknowledgments
Financial/nonnancial disclosures: The authors have reported to CHEST that no potential conicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
References
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249. 2. Goldstraw P, ed. International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology. 1st ed. Orange Park, FL: Editorial Rx Press; 2009. 3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009. 4. Goldstraw P. The 7th rdition of TNM in lung cancer: what now? J Thorac Oncol. 2009;4(6):671-673.
www.chestpubs.org
5. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136(1):260-271. 6. Goldstraw P, Crowley J, Chansky K, et al; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classication of malignant tumours. J Thorac Oncol. 2007;2(8):706-714. 7. Lababede O, Meziane MA, Rice TW. TNM staging of lung cancer: a quick reference chart. Chest. 1999;115(1):233-235. 8. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P; Members of IASLC Staging Committee. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classication for lung cancer. J Thorac Oncol. 2009;4(5):568-577.
CHEST / 139 / 1 / JANUARY, 2011
189
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians
Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer : Quick Reference Chart and Diagrams Omar Lababede, Moulay Meziane and Thomas Rice Chest 2011;139; 183-189 DOI 10.1378/chest.10-1099 This information is current as of March 8, 2012
Updated Information & Services Updated Information and services can be found at: http://chestjournal.chestpubs.org/content/139/1/183.full.html References This article cites 6 articles, 2 of which can be accessed free at: http://chestjournal.chestpubs.org/content/139/1/183.full.html#ref-list-1 Permissions & Licensing Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at: http://www.chestpubs.org/site/misc/reprints.xhtml Reprints Information about ordering reprints can be found online: http://www.chestpubs.org/site/misc/reprints.xhtml Citation Alerts Receive free e-mail alerts when new articles cite this article. To sign up, select the "Services" link to the right of the online article. Images in PowerPoint format Figures that appear in CHEST articles can be downloaded for teaching purposes in PowerPoint slide format. See any online figure for directions.
Downloaded from chestjournal.chestpubs.org by guest on March 8, 2012 2011 American College of Chest Physicians